Free Trial

Regeneron, MyoKardia rise; DraftKings, AMC fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:

HMS Holdings Corp., up $3.02 to $27.39.

The health care information technology company is considering a sale, according to media reports.

MyoKardia Inc., up $80.74 to $220.34.

Bristol-Myers Squibb is buying the biotechnology company for about $13 billion.

DraftKings Inc., down $3.23 to $60.55.

The sports betting company announced a stock offering of 32 million shares, half of which are being sold by stockholders.

AMC Entertainment Holdings Inc., down 52 cents to $4.13.

Rival theater chain Cineworld is severely cutting operations as the industry struggles with lockdowns and capacity limits.

Eidos Therapeutics Inc., up 21.59 to $73.51.

BridgeBio Pharma is buying the remaining 36.3% of the drug developer that it doesn't already own.

The RealReal Inc., up $1.25 to $16.00.

The online luxury consignment company is partnering with Gucci to launch an online shop for the company's pre-owned goods.

Norwegian Cruise Line Holdings Ltd., down 28 cents to $16.99.

The cruise line operator extended its suspension of cruises through Nov. 30.

Regeneron Pharmaceuticals Inc., up $40.28 to $605.08.

President Donald Trump received the biotechnology company’s experimental COVID-19 treatment.

Should You Invest $1,000 in RealReal Right Now?

Before you consider RealReal, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RealReal wasn't on the list.

While RealReal currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Regeneron Pharmaceuticals (REGN)
4.8321 of 5 stars
$567.741.4%0.62%14.45Moderate Buy$814.57
DraftKings (DKNG)
4.455 of 5 stars
$42.98-3.6%N/A-51.78Moderate Buy$53.93
Eidos Therapeutics (EIDX)N/A$122.21flatN/A-46.12N/AN/A
Norwegian Cruise Line (NCLH)
4.6621 of 5 stars
$22.58-2.5%N/A13.05Moderate Buy$25.16
HMS (HMSY)N/A$36.98flatN/A60.61N/AN/A
AMC Entertainment (AMC)
2.9742 of 5 stars
$3.3511.7%N/A-3.42Reduce$4.26
RealReal (REAL)
1.537 of 5 stars
$5.29-2.6%N/A-4.68Moderate Buy$8.40
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines